1. Home
  2. IKNA vs MDIA Comparison

IKNA vs MDIA Comparison

Compare IKNA & MDIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • MDIA
  • Stock Information
  • Founded
  • IKNA 2016
  • MDIA 2019
  • Country
  • IKNA United States
  • MDIA United States
  • Employees
  • IKNA N/A
  • MDIA N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • MDIA Broadcasting
  • Sector
  • IKNA Health Care
  • MDIA Consumer Discretionary
  • Exchange
  • IKNA Nasdaq
  • MDIA Nasdaq
  • Market Cap
  • IKNA 74.8M
  • MDIA 61.4M
  • IPO Year
  • IKNA 2021
  • MDIA N/A
  • Fundamental
  • Price
  • IKNA $1.57
  • MDIA $1.20
  • Analyst Decision
  • IKNA Buy
  • MDIA
  • Analyst Count
  • IKNA 2
  • MDIA 0
  • Target Price
  • IKNA $3.00
  • MDIA N/A
  • AVG Volume (30 Days)
  • IKNA 399.7K
  • MDIA 54.5K
  • Earning Date
  • IKNA 11-07-2024
  • MDIA 12-31-2024
  • Dividend Yield
  • IKNA N/A
  • MDIA N/A
  • EPS Growth
  • IKNA N/A
  • MDIA N/A
  • EPS
  • IKNA N/A
  • MDIA N/A
  • Revenue
  • IKNA $659,000.00
  • MDIA $69,296,000.00
  • Revenue This Year
  • IKNA N/A
  • MDIA N/A
  • Revenue Next Year
  • IKNA N/A
  • MDIA N/A
  • P/E Ratio
  • IKNA N/A
  • MDIA N/A
  • Revenue Growth
  • IKNA N/A
  • MDIA 94.96
  • 52 Week Low
  • IKNA $1.22
  • MDIA $0.40
  • 52 Week High
  • IKNA $2.17
  • MDIA $6.86
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 42.72
  • MDIA 45.67
  • Support Level
  • IKNA $1.62
  • MDIA $1.08
  • Resistance Level
  • IKNA $1.94
  • MDIA $1.25
  • Average True Range (ATR)
  • IKNA 0.10
  • MDIA 0.09
  • MACD
  • IKNA -0.01
  • MDIA -0.01
  • Stochastic Oscillator
  • IKNA 16.85
  • MDIA 41.38

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About MDIA Mediaco Holding Inc.

MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales and events including sponsorships and ticket sales, licensing, and syndication.

Share on Social Networks: